mRNA

It was a dark morning in the Covid-19 fight. The market is looking for hope at Johnson & Johnson.

J&J can share findings from the Phase 3 vaccine trial this week

CDC: Moderna’s COVID-19 vaccine may cause allergic reaction in some people

Merck Scrap Covid-19 Vaccine Candidates

California officials investigate death of person who received the Covid-19 vaccine hours earlier

Johnson & Johnson targets 100 million doses of vaccine by spring. The stock market is counting on that.

Studies of South African coronavirus strains raise concerns about immune response

California health official calls for 300,000 vaccinations to be suspended Modern after reports of allergic reactions

Argentina is a testing ground for Moscow’s Global Vaccine Drive

Moderna, Inc. (MRNA), (BNTX) – Moderna Plans COVID-19 Booster Shots: What you need to know

Extra Covid-19 injections pose a dilemma for vaccination sites

J&J Hits Vaccine Production Snags, New York Times Reports